Statistics
Publications
13
Citations
516
H-Index
12
Active since
1969
Rebecca E. Parker is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and pharmacology.
Publications per year
1969–2021
13
13
Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells
Mohamed Rahmani, Jewel Nkwocha, Elisa Hawkins et al. · Cancer Research · 2018 · 144 citations · Full text
Medicine, Oncology, Pharmacology +17
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
Alisa B. Lee‐Sherick, Kristen M. Jacobsen, Curtis J. Henry et al. · JCI Insight · 2018 · 73 citations · Full text
Medicine, Immunology, Oncology +17
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
Nellie K. McDaniel, Christopher T. Cummings, Mari Iida et al. · Molecular Cancer Therapeutics · 2018 · 67 citations · Full text
Medicine, Oncology, Pharmacology +17
Mohamed Rahmani, Mandy Mayo Aust, Edith P. Hawkins et al. · Haematologica · 2015 · 31 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 13